Initial Study of the Minimally Invasive RheOx(TM) Device Demonstrates Positive Results for Chronic Bronchitis Patients - P&T Community

Initial Study of the Minimally Invasive RheOx(TM) Device Demonstrates Positive Results for Chronic Bronchitis Patients  P&T Community

DALLAS, May 23, 2019 /PRNewswire/ -- Gala Therapeutics, Inc. (Gala), a clinical-stage developer of medical devices to treat pulmonary disease, today ...